Labcorp to Acquire Invitae Under US Bankruptcy Code Section 363
Shots:
- Labcorp won Invitae’s auction bid, in the sale process under US Bankruptcy Code Section 363
- Following the auction, LabCorp will acquire all assets for $239M in cash, plus other non-cash consideration
- The current hearing date of sale approval is May 6, 2024. Deal closing is expected by Q3’24, with court approval, customary regulatory clearances and closing conditions
Ref: Labcorp | Image: Labcorp
Related News:- Labcorp Launched Neurofilament Light Chain Blood Test to Identify Neurodegenerative Disease
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
